Click Here Learn More
Friday, February 13, 2015
FDA Approves Drug for Advanced Thyroid Cancer
Progression-free survival with Lenvima was nearly five times longer compared to a placebo
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment